Home › Funds › SOFTBANK GROUP CORP. › ABCL

SOFTBANK GROUP CORP. position in ABCL

ABCELLERA BIOLOGICS INC · Health Care

SOFTBANK GROUP CORP. reported holding 345,161 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q2 2026 13F filing — a position valued at US$2.7M, representing 0.01% of its reported portfolio and ranking #26 among its reported holdings. SOFTBANK GROUP CORP. has disclosed ABCL holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)345.16K sh
Reported value held$2.71M
Portfolio Weight0.01%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SOFTBANK GROUP CORP.'s ABCL position evolved

SOFTBANK GROUP CORP. first disclosed a stake in ABCL in Q4 2025 at 345,161 shares (US$1.2M). The position peaked in Q2 2026 at 345,161 shares, worth US$2.7M. Across 3 filings, SOFTBANK GROUP CORP. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 345,161 shares valued at US$2.7M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 345.16K $1.18M New
Q1 2026 345.16K $1.20M Hold
Q2 2026 345.16K $2.71M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABCL and 13F data

ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 37 other funds we track also report a position in ABCL — the largest reported positions include BAKER BROS. ADVISORS LP (US$259.1M), ArrowMark Colorado Holdings LLC (US$32.2M), Guardian Partners Inc. (US$8.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABCL

All ABCL fund holders →

FAQ

How long has SOFTBANK GROUP CORP. held ABCL?

SOFTBANK GROUP CORP. has disclosed ABCL holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is SOFTBANK GROUP CORP.'s current position in ABCL?

As of Q2 2026, SOFTBANK GROUP CORP. holds 345.16K shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $2.71M, representing 0.01% of its reported portfolio and ranking #26.

Has SOFTBANK GROUP CORP. been buying or selling ABCL?

In the latest 13F filing (Q2 2026), SOFTBANK GROUP CORP. held unchanged its position in ABCL. The position peaked in Q2 2026 at 345.16K shares.

Which other funds hold ABCL?

Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, Guardian Partners Inc., among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.